Professional paper

Fixed dose combination of perindopril and indapamide in the treatment of arterial hypertension.

Alenka Kmecl ; Krka d. d., Novo mesto, Slovenia
Polona Knavs-Vrhunec ; Krka d. d., Novo mesto, Slovenia
Breda Barbič-Žagar orcid.org/0000-0002-1173-7361 ; Krka d. d., Novo mesto, Slovenia

Abstract

Adherence of patients to therapy has in the past years been identified as one of the major factors influencing blood pressure (BP) control in treated population. The use of fixed dose combinations improves ad- herence, and consequentially increases the rate of BP control. The fixed dose combination of perindopril and indapamide deserves special attention because of the large-scale outcome trials which have shown its advantages beyond blood pressure lowering as well as improved cardiovascular prognosis. The results of the clinical trials have also been confirmed in daily clinical practice. With its fixed dose combination of perindopril and indapamide Krka offers the opportunity of individualized therapy either for start or for continuation of antihypertensive treatment.

Keywords

arterial hypertension; blood pressure control; fixed dose combination, perindopril; indapamide

Hrčak ID:

105310

URI

https://hrcak.srce.hr/105310

Publication date:

4.7.2013.

Article data in other languages: croatian

Visits: 1.693 *